MustGrow Biologics Corp.
MGRO.V
TSX
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -88.64% | 8.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -88.64% | 8.45% | |||
| Cost of Revenue | -78.82% | 30.43% | |||
| Gross Profit | -79.27% | -157.70% | |||
| SG&A Expenses | -49.08% | -49.25% | |||
| Depreciation & Amortization | -- | -1.03% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -58.96% | -29.76% | |||
| Operating Income | 39.40% | 43.00% | |||
| Income Before Tax | 58.38% | 14.64% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 58.38% | 14.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 36.82% | 14.64% | |||
| EBIT | 39.40% | 43.00% | |||
| EBITDA | 39.68% | 43.18% | |||
| EPS Basic | 39.84% | 20.50% | |||
| Normalized Basic EPS | 39.42% | 48.51% | |||
| EPS Diluted | 39.84% | 20.50% | |||
| Normalized Diluted EPS | 39.42% | 48.51% | |||
| Average Basic Shares Outstanding | 5.14% | 7.67% | |||
| Average Diluted Shares Outstanding | 5.14% | 7.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||